514 filings
Page 12 of 26
8-K
vbhvf5j0evjz
12 Apr 12
Arqule Prices Public Offering of Common Stock
12:00am
424B3
uz8 yii8ukgj74g4u6
10 Apr 12
Prospectus supplement
12:00am
S-3MEF
gh1o5vq9djqjs43e3
10 Apr 12
Registration of additional securities for an S-3
12:00am
8-K
banf p0tc8
10 Apr 12
Arqule Announces Proposed Public Offering
12:00am
CT ORDER
jf9ws0h1f
21 Mar 12
Confidential treatment order
12:00am
8-K
abhp28x
1 Mar 12
Results of Operations and Financial Condition
12:00am
8-K/A
j2pc ptz55yug724u
27 Feb 12
Financial Statements and Exhibits
12:00am
8-K
p3al ugs7z8
24 Feb 12
Departure of Directors or Certain Officers
12:00am
8-K
6pgiedffksf30u2
17 Jan 12
Arqule Announces Tivantinib Meets Primary Endpoint, Significantly
12:00am
S-8
t5cdv
30 Nov 11
Registration of securities for employees
12:00am
S-8
z7imzvlf jvp48
30 Nov 11
Registration of securities for employees
12:00am
S-8
lrnm xia4
30 Nov 11
Registration of securities for employees
12:00am
8-K
xfj 4xijd3hr
10 Nov 11
Daiichi Sankyo to License ARQ 092 from ArQule, the First New Compound Resulting
12:00am
8-K
8fp7 quxdz2
10 Nov 11
Arqule Announces Third Quarter Fiscal 2011 Results
12:00am
8-K
u2las3axk7w4c8t
9 Aug 11
Other Events
12:00am
8-K
klmy jnm4e6
4 Aug 11
Arqule Reports Second Quarter 2011 Financial Results
12:00am